Prescription drug · ANDA
ChlorproMAZINE Hydrochloride (chlorpromazine) NDC 63304-185
Chlorpromazine hydrochloride 10 mg/1 · Tablet, Sugar coated · Oral · Sun Pharmaceutical Industries Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63304-185-01 | 63304018501 | 100 TABLET, SUGAR COATED in 1 BOTTLE (63304-185-01)Marketed from Nov 18, 2020 | |
| 63304-185-10 | 63304018510 | 1000 TABLET, SUGAR COATED in 1 BOTTLE (63304-185-10)Marketed from Nov 18, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ChlorproMAZINE Hydrochloride
- Generic name (nonproprietary)
- chlorpromazine
- Active ingredients
- Chlorpromazine hydrochloride — 10 mg/1
- Dosage form
- Tablet, Sugar coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214256
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 63304-185_536b2c5b-1d4f-a2f5-e063-6394a90a50f0SPL ID 536b2c5b-1d4f-a2f5-e063-6394a90a50f0SPL set ID 432cd4ca-c728-48ff-beec-2485f5e02512RxCUI 991039, 991044, 991188, 991194, 991336UNII 9WP59609J6
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463304018501followed by a unit qualifier and the quantityPackage 63304-0185-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups. For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanyi…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214256
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| ChlorproMAZINE Hydrochloridechlorpromazine | Chlorpromazine hydrochloride 200 mg/1 | Tablet, Sugar coatedOral | Sun Pharmaceutical Industries Inc | 63304-083 |
| ChlorproMAZINE Hydrochloridechlorpromazine | Chlorpromazine hydrochloride 100 mg/1 | Tablet, Sugar coatedOral | Sun Pharmaceutical Industries Inc | 63304-114 |
| ChlorproMAZINE Hydrochloridechlorpromazine | Chlorpromazine hydrochloride 50 mg/1 | Tablet, Sugar coatedOral | Sun Pharmaceutical Industries Inc | 63304-122 |
| ChlorproMAZINE Hydrochloridechlorpromazine | Chlorpromazine hydrochloride 25 mg/1 | Tablet, Sugar coatedOral | Sun Pharmaceutical Industries Inc | 63304-143 |